| News | Events |
| Publications | Companies |
| Clinical Trials |
Monthly Archives: December 2003
-
Copehhagen, December 16, 2003 Santaris Pharma A/S, the Danish biopharmaceutical company developing high affinity antisense drugs for the treatment of cancer, today announced that it has won a significant patent opposition case at the European Patent Office (EPO) as a result of which the EPO has revoked European Patent no. EP... Contine Reading & Discuss→

